Slowing of Cortical Gray Matter Atrophy with Teriflunomide is Associated with Delayed Conversion to Clinically Definite MS
Keyword(s):
2012 ◽
Vol 33
(8)
◽
pp. 1573-1578
◽
Keyword(s):
2012 ◽
Vol 78
(Meeting Abstracts 1)
◽
pp. P03.063-P03.063
Keyword(s):
Keyword(s):
Keyword(s):